The significance of immunosuppression and antigenic stimulation in the development of malignant lymphomas.
D000818:Animals; D000921:Antibody-Producing Cells / Q000187:drug effects*; D000937:Antigen-Antibody Reactions; D000970:Antineoplastic Agents / Q000009:adverse effects / Q000494:pharmacology*; D001379:Azathioprine / Q000494:pharmacology; D003520:Cyclophosphamide / Q000494:pharmacology; D004195:Disease Models, Animal; D006801:Humans; D007165:Immunosuppression Therapy; D008223:Lymphoma / Q000139:chemically induced / Q000209:etiology* / Q000276:immunology; D016403:Lymphoma, Large B-Cell, Diffuse / Q000139:chemically induced; D051379:Mice; D008807:Mice, Inbred BALB C; D008811:Mice, Inbred DBA
D000970:Antineoplastic Agents; D003520:Cyclophosphamide; D001379:Azathioprine